Search research articles
Contact Us
Filters
Showing results (31-40 of 512) with videos related to
Page
of 52
Sort By:
Clinical Pharmacology and Therapeutics
|
October 23, 2012
Advancing pharmacometrics and systems pharmacology
S A Waldman, A Terzic
Clinical Chemistry
|
May 30, 2008
MicroRNA signatures as diagnostic and therapeutic targets
Scott A Waldman, Andre Terzic
Biomarkers in Medicine
|
February 8, 2013
Guanylyl cyclase C as a biomarker in colorectal cancer
Terry Hyslop, Scott A Waldman
Clinical Pharmacology and Therapeutics
|
January 21, 2016
Bioinnovation Enterprise: An engine driving breakthrough therapies
S A Waldman, A Terzic
Clinical Pharmacology and Therapeutics
|
February 19, 2016
Big Data Transforms Discovery-Utilization Therapeutics Continuum
S A Waldman, A Terzic
Clinical Pharmacology and Therapeutics
|
January 23, 2014
Managing the innovation supply chain to maximize personalized medicine
S A Waldman, A Terzic
Clinical and Translational Science
|
August 20, 2010
Molecular therapy drives patient-centric health care paradigms
Scott A Waldman, Andre Terzic
Clinical and Translational Science
|
February 26, 2011
Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise
Scott A Waldman, Andre Terzic
Clinical Pharmacology and Therapeutics
|
August 8, 2017
Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
S A Waldman, A Terzic
Biomarkers in Medicine
|
February 8, 2013
Translational medicine individualizes healthcare discovery, development and delivery. Foreword
Scott A Waldman, Andre Terzic
Page
of 52
Search research articles
Search
Showing results (31-40 of 512) with videos related to
Sort By:
Page
of 52
Clinical Pharmacology and Therapeutics
|
October 23, 2012
Advancing pharmacometrics and systems pharmacology
S A Waldman, A Terzic
Clinical Chemistry
|
May 30, 2008
MicroRNA signatures as diagnostic and therapeutic targets
Scott A Waldman, Andre Terzic
Biomarkers in Medicine
|
February 8, 2013
Guanylyl cyclase C as a biomarker in colorectal cancer
Terry Hyslop, Scott A Waldman
Clinical Pharmacology and Therapeutics
|
January 21, 2016
Bioinnovation Enterprise: An engine driving breakthrough therapies
S A Waldman, A Terzic
Clinical Pharmacology and Therapeutics
|
February 19, 2016
Big Data Transforms Discovery-Utilization Therapeutics Continuum
S A Waldman, A Terzic
Clinical Pharmacology and Therapeutics
|
January 23, 2014
Managing the innovation supply chain to maximize personalized medicine
S A Waldman, A Terzic
Clinical and Translational Science
|
August 20, 2010
Molecular therapy drives patient-centric health care paradigms
Scott A Waldman, Andre Terzic
Clinical and Translational Science
|
February 26, 2011
Clinical translational science 2020: disruptive innovation redefines the discovery-application enterprise
Scott A Waldman, Andre Terzic
Clinical Pharmacology and Therapeutics
|
August 8, 2017
Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
S A Waldman, A Terzic
Biomarkers in Medicine
|
February 8, 2013
Translational medicine individualizes healthcare discovery, development and delivery. Foreword
Scott A Waldman, Andre Terzic
Page
of 52